cardiovascular · Mechanism Report
Does redox-active iron promote lipid peroxidation and oxidative modification of LDL?
Redox-active iron catalyzes Fenton chemistry that drives lipid peroxidation and converts native LDL into oxidized, atherogenic LDL, posing a direct threat to vascular health.
This is what AI claimed
Redox-active iron can promote lipid peroxidation and oxidative modification of LDL particles.
Executive summary
The claim states that labile Fe2+ generates hydroxyl and downstream radicals that initiate and amplify lipid peroxidation, producing reactive lipid breakdown products. It further describes iron binding to apoB-100 and enhanced redox cycling—especially in acidic lysosomes—leading to LDL oxidation and contributing to endothelial ferroptosis and vascular injury.
Verified conclusion
Redox-active iron is a highly reactive catalyst capable of driving cellular lipid damage and modifying circulating lipoproteins, posing a direct threat to vascular health.
Molecular mechanisms of lipid peroxidation
- Radical generation: Divalent iron ($Fe^{2+}$) in the labile iron pool drives the classical Fenton reaction with hydrogen peroxide, generating highly reactive hydroxyl radicals ($\cdot$OH).
- Propagation cascade: These radicals abstract hydrogen atoms from membrane polyunsaturated fatty acids (PUFAs), producing lipid radicals ($L^{\cdot}$) and lipid peroxyl radicals ($LOO^{\cdot}$).
- Amplification: Subsequent $Fe^{2+}$-catalyzed decomposition of lipid hydroperoxides ($LOOH$) yields aggressive alkoxyl radicals ($LO^{\cdot}$). This feedback loop leads to membrane disruption and generates toxic, non-enzymatic end-products like malondialdehyde (MDA) and $F_2$-isoprostanes.
Oxidative modification of LDL and vascular injury
- ApoB-100 modification: Redox-active iron binds directly to apolipoprotein B-100 (apoB-100) on LDL particles. Local reductants, such as superoxide or homocysteine, reduce $Fe^{3+}$ to $Fe^{2+}$, initiating localized Fenton-type chemistry.
- Atherogenic transition: This lipid peroxidation yields reactive aldehydes (MDA and 4-hydroxynonenal) that adduct apoB-100, transforming native LDL into highly atherogenic oxidized LDL (oxLDL).
- Lysosomal acceleration: This reaction is highly accelerated in acidic macrophage lysosomes (pH 4.5–5.0), where enhanced iron solubility drives rapid redox cycling.
- Endothelial ferroptosis: Accumulating oxLDL and intracellular iron synergistically deplete GPX4 and trigger ferroptosis in vascular endothelial cells, accelerating plaque progression.
Bottom line
- Redox-active iron directly promotes both systemic lipid peroxidation and the oxidative modification of LDL particles through Fenton chemistry, generating atherogenic oxLDL and driving endothelial cell death via ferroptosis.
References
- Hydrogen peroxide and iron ions can modulate lipid peroxidation, apoptosis, and the cell cycle, but do not have a significant effect on DNA double-strand break. — linkinghub.elsevier.com
- Current Use of Fenton Reaction in Drugs and Food - PMC — pmc.ncbi.nlm.nih.gov
- Fenton Reaction - an overview | ScienceDirect Topics — sciencedirect.com
- Lipid Peroxidation and Iron Metabolism: Two Corner Stones ... - PMC — pmc.ncbi.nlm.nih.gov
- Labile Iron Pool: The Main Determinant of Cellular Response to ... — pubmed.ncbi.nlm.nih.gov
- Hydroxyl radical is produced via the Fenton reaction in ... - PubMed — pubmed.ncbi.nlm.nih.gov
- Hydrogen peroxide and iron ions can modulate lipid peroxidation ... — sciencedirect.com
- What Is Responsible for the Initiating Chemistry of Iron-Mediated ... — pubs.acs.org
- LDL oxidized with iron in the presence of homocysteine/cystine at ... — sciencedirect.com
- Oxidation of Low-Density Lipoprotein by Iron at Lysosomal pH - PMC — pmc.ncbi.nlm.nih.gov
- Oxidation of Low-Density Lipoprotein by Iron at Lysosomal pH — pubs.acs.org
- Oxidized low-density lipoproteins and their contribution to ... — explorationpub.com
- Iron as a catalyst of human low-density lipoprotein oxidation - PubMed — pubmed.ncbi.nlm.nih.gov
- Mechanisms of metal ion-dependent oxidation of human low density ... — pubmed.ncbi.nlm.nih.gov
- Reduction of Copper, but Not Iron, by Human Low Density Lipoprotein (LDL) — linkinghub.elsevier.com
- The Fenton Activity of Iron(III) in the Presence of Deferiprone — sciencedirect.com
- The isoprostanes—25 years later - PMC - NIH — pmc.ncbi.nlm.nih.gov
- Isoprostane Generation and Function - PMC - NIH — pmc.ncbi.nlm.nih.gov
- Key issues in F2-isoprostane analysis - Portland Press — portlandpress.com
- Ferroptosis: the potential value target in atherosclerosis - Nature — nature.com
- Iron, lipid peroxidation, and ferroptosis play pathogenic roles in ... — academic.oup.com
- Inhibition of ferroptosis alleviates atherosclerosis through attenuating lipid peroxidation and endothelial dysfunction in mouse aortic endothelial cell. — linkinghub.elsevier.com
- SREBP‐1‐mediated lipogenesis confers resistance to ferroptosis and improves endothelial injury — faseb.onlinelibrary.wiley.com
See a full patient report verified like this
Book a walkthrough